International Stem Cell Corporation's Liver Program Receives Award - Wall Street Journal

International Stem Cell Corporation s Liver Program Receives AwardWall Street JournalInternational Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. ISCO s core technology, parthenogenesis read more

http://blog.zandcell.com/international-stem-cell-corporations-liver-program-receives-award-wall-street-journal/?utm_source=rss&utm_medium=rss&utm_campaign=international-stem-cell-corporations-liver-program-receives-award-wall-street-journal